EDGAR Filing Documents for 0001654954-18-005777

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001654954-18-005777

Filing Date

2018-05-22

Accepted

2018-05-22 16:10:43

Documents

Period of Report

2018-05-18

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	section16.html	4
1	PRIMARY DOCUMENT	section16.xml	4	3560
	Complete submission text file	0001654954-18-005777.txt		5046

Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014

Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884

Cellular Biomedicine Group, Inc. (Issuer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 17901 VON KARMAN AVENUE, SUITE 150 IRVINE CA 92614

Business Address

Type: 4 | Act: 34 | File No.: 001-36498 | Film No.: 18852547